Literature DB >> 31896949

African-Caribbean Cancer Consortium Scientific and Training Conference 2017.

C Ragin1, J S Oliver1, D N Cabral1, M Harlemon1, D Louden1,2, B F Morrison-Blidgen1,2, K Alleyne-Mike1,2, K Ashing1, R Butler1,2, S Gathere1,3, S George1, D Halliday1,2, M Jackson1,2, V Odero-Marah1, V Roach1,2, R Roberts1,2, S Slewion1,3.   

Abstract

The sixth International African-Caribbean Cancer Consortium (AC3) Conference was held 6-9 October 2017 in Miami, Florida, U.S.A. The conference was open to all researchers, trainees, clinical and public health professionals, and community members, and served as an international hub for the United States, the Caribbean, and Africa. Sessions included AC3 collaboration meetings, cancer surveillance and research skills training workshops, and a community cancer prevention conference. 2019 Multimed Inc.

Entities:  

Keywords:  Disparities

Mesh:

Year:  2019        PMID: 31896949      PMCID: PMC6927787          DOI: 10.3747/co.26.5305

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  7 in total

1.  Inflammation polymorphisms and prostate cancer risk in Jamaican men: Role of obesity/body size.

Authors:  Bhawna Dubey; Maria D Jackson; Charnita Zeigler-Johnson; Karthik Devarajan; Rafael E Flores-Obando; Norma McFarlane-Anderson; Marshall K Tulloch-Reid; William Aiken; Kevin Kimbro; Dominique Z Jones; LaCreis R Kidd; Camille Ragin
Journal:  Gene       Date:  2017-09-10       Impact factor: 3.688

2.  Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study.

Authors:  Lacreis R Kidd; Dominique Z Jones; Erica N Rogers; Nayla C Kidd; Sydney Beache; James E Rudd; Camille Ragin; Maria Jackson; Norma McFarlane-Anderson; Marshall Tulloch-Reid; Seian Morrison; Guy N Brock; Shirish S Barve; Kevin S Kimbro
Journal:  Hered Cancer Clin Pract       Date:  2012-11-20       Impact factor: 2.857

3.  Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent.

Authors:  E N Rogers; D Z Jones; N C Kidd; S Yeyeodu; G Brock; C Ragin; M Jackson; N McFarlane-Anderson; M Tulloch-Reid; K Sean Kimbro; L R Kidd
Journal:  Genes Immun       Date:  2013-05-09       Impact factor: 2.676

4.  The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study.

Authors:  Dominique Z Jones; Camille Ragin; Nayla C Kidd; Rafael E Flores-Obando; Maria Jackson; Norma McFarlane-Anderson; Marshall Tulloch-Reid; Kevin S Kimbro; Lacreis R Kidd
Journal:  Hered Cancer Clin Pract       Date:  2013-12-23       Impact factor: 2.857

5.  The 4th Bi-annual international African-Caribbean Cancer Consortium conference: building capacity to address cancer health disparities in populations of African descent.

Authors:  Elizabeth Blackman; Jasmine Campbell; Carlene Bowen; Ernestine Delmoor; Gilda Jean-Louis; Raphiatou Noumbissi; Yvonne O'Garro; Oni Richards-Waritay; Stanley Straughter; Vera Tolbert; Barbara Wilson; Camille Ragin
Journal:  Infect Agent Cancer       Date:  2014-10-22       Impact factor: 2.965

6.  African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors.

Authors:  Camille C Ragin; Emanuela Taioli; Norma McFarlane-Anderson; Gordon Avery; Franklyn Bennett; Adelia Bovell-Benjamin; Angela Brown Thompson; Agatha Carrington; Lydia Campbell-Everett; Jacqueline Ford; Anselm Hennis; Maria Jackson; Sandra Lake; M Cristina Leske; Carol Magai; Barbara Nemesure; Alfred Neugut; Folakemi Odedina; Michael Okobia; Alan Patrick; Wallis Best Plummer; R Renee Reams; Robin Roberts; Sharaneen Scott-Hastings; Sangita Sharma; Victor Wheeler; Suh-Yuh Wu; Clareann Bunker
Journal:  Infect Agent Cancer       Date:  2007-09-24       Impact factor: 2.965

7.  The Second International African-Caribbean Cancer Consortium for the study of viral, genetic and environmental cancer risk factors.

Authors:  Camille Ragin; Emanuela Taioli
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.